JPS59196900A - 新規オリゴ配糖体パ−ビコサイド類およびそれを含有してなる抗真菌剤 - Google Patents
新規オリゴ配糖体パ−ビコサイド類およびそれを含有してなる抗真菌剤Info
- Publication number
- JPS59196900A JPS59196900A JP58071937A JP7193783A JPS59196900A JP S59196900 A JPS59196900 A JP S59196900A JP 58071937 A JP58071937 A JP 58071937A JP 7193783 A JP7193783 A JP 7193783A JP S59196900 A JPS59196900 A JP S59196900A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- pervicoside
- antifungal agent
- perpicoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940121375 antifungal agent Drugs 0.000 title claims abstract description 14
- 239000003429 antifungal agent Substances 0.000 title claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 26
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- -1 methanol Chemical compound 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 241000451664 Holothuria pervicax Species 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 238000010898 silica gel chromatography Methods 0.000 abstract description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- DEHSMOLOWCNYJI-CVURUQKOSA-M chembl504650 Chemical compound [Na+].O[C@@H]1[C@@H](OC)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H](OC[C@H]([C@@H]3O)OS([O-])(=O)=O)O[C@@H]3C([C@H]4[C@](C=5[C@H]([C@@]6(CC[C@H]7[C@]6(C(O[C@]7(CCCC(C)C)C)=O)[C@@H](O)C=5)C)CC4)(C)CC3)(C)C)O[C@@H]2C)O)O[C@H](CO)[C@H]1O DEHSMOLOWCNYJI-CVURUQKOSA-M 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- RGMKMMVBOLIWCC-UHFFFAOYSA-M neothyoside a Chemical compound [Na+].OC1C(OC)C(O)C(CO)OC1OC1C(O)C(OC2C(C(O)C(OC3C(OCC(C3O)OS([O-])(=O)=O)OC3C(C4CC=C5C6(C)CCC7C6(C(OC7(CCCC(C)(C)OC(C)=O)C)=O)C(O)CC5C4(C)CC3)(C)C)OC2C)O)OC(CO)C1O RGMKMMVBOLIWCC-UHFFFAOYSA-M 0.000 abstract 1
- KQZXVZVRFIRDCU-UHFFFAOYSA-M neothyoside c Chemical compound [Na+].OC1C(OC)C(O)C(CO)OC1OC1C(O)C(OC2C(C(O)C(OC3C(OCC(C3O)OS([O-])(=O)=O)OC3C(C4CC=C5C6(C)CCC7C6(C(OC7(CCC=C(C)C)C)=O)C(O)CC5C4(C)CC3)(C)C)OC2C)O)OC(CO)C1O KQZXVZVRFIRDCU-UHFFFAOYSA-M 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 14
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 241000251511 Holothuroidea Species 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 102220043690 rs1049562 Human genes 0.000 description 3
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000012745 brilliant blue FCF Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 229960002389 glycol salicylate Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000736772 Uria Species 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000001032 anti-candidal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 102220223891 rs370721650 Human genes 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000007449 t5 medium Substances 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58071937A JPS59196900A (ja) | 1983-04-22 | 1983-04-22 | 新規オリゴ配糖体パ−ビコサイド類およびそれを含有してなる抗真菌剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58071937A JPS59196900A (ja) | 1983-04-22 | 1983-04-22 | 新規オリゴ配糖体パ−ビコサイド類およびそれを含有してなる抗真菌剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59196900A true JPS59196900A (ja) | 1984-11-08 |
| JPH0368880B2 JPH0368880B2 (enrdf_load_stackoverflow) | 1991-10-30 |
Family
ID=13474917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58071937A Granted JPS59196900A (ja) | 1983-04-22 | 1983-04-22 | 新規オリゴ配糖体パ−ビコサイド類およびそれを含有してなる抗真菌剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59196900A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104991028A (zh) * | 2015-07-31 | 2015-10-21 | 北京市药品检验所 | Lc-ms测试物中不挥发性缓冲盐含量的降低方法 |
-
1983
- 1983-04-22 JP JP58071937A patent/JPS59196900A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104991028A (zh) * | 2015-07-31 | 2015-10-21 | 北京市药品检验所 | Lc-ms测试物中不挥发性缓冲盐含量的降低方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0368880B2 (enrdf_load_stackoverflow) | 1991-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19638870A1 (de) | Verbindungen mit antimykotischer und cytostatischer Wirkung, Herstellungsverfahren, Mittel und DSM 11 092 | |
| AT394725B (de) | Verfahren zur herstellung von neuen mitomycin-c-analogen | |
| Takeda et al. | Metallo-anthocyanins. I Reconstruction of commelinin from its components, awobanin, flavocommelin and magnesium | |
| DE1935967C3 (de) | Naphthacenderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
| DE2149750A1 (de) | Erythromycin-Derivate | |
| JPS59196900A (ja) | 新規オリゴ配糖体パ−ビコサイド類およびそれを含有してなる抗真菌剤 | |
| Seiber et al. | Three new cardenolides from the milkweeds Asclepias eriocarpa and A. labriformis | |
| DE2943581A1 (de) | Valylleucyllysinderivate, verfahren zu deren herstellung und deren verwendung | |
| DE1670377C3 (de) | Verfahren zur Herstellung von Rifamycinderivaten | |
| JPS6358839B2 (enrdf_load_stackoverflow) | ||
| CN109134588B (zh) | 一种新化合物及其制备方法和在抗衰老化妆品方面的用途 | |
| CH640870A5 (de) | Verfahren zur herstellung von 9-desacetyl-9-formyl-n-trifluoracetyldaunorubicin. | |
| JPS6245880B2 (enrdf_load_stackoverflow) | ||
| Itô et al. | Structure and absolute configuration of α-kessyl alcohol and kessyl glycol | |
| DE69518258T2 (de) | Kortikoidderivate und pharmazeutische und kosmetische Zusammensetzungen | |
| DE2324993C3 (de) | 4'-dehydro-oleandrin, verfahren zu dessen herstellung sowie ein diese verbindung enthaltendes pharmazeutisches praeparat | |
| DE2220796C2 (de) | Verfahren zur Herstellung von 3-Glucos-2-yl-3-desmethylthiocolchicin und von 2-Glucos-2-yl-2-desmethylthiocolchicin | |
| DE1807585C3 (de) | 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel | |
| SCHRECKER et al. | Components of Podophyllin. XIX. 2 Isomorphism in the Podophyllotoxin Series | |
| DE2403429A1 (de) | Insektizide | |
| DE928286C (de) | Verfahren zur Herstellung eines neuen, analgetisch wirksamen 1-Phenyl-pyrazolderivates | |
| DE1445417A1 (de) | Verfahren zur Herstellung von neuen Hexitestern der Nikotinsaeure | |
| DE750481C (de) | Verfahren zur Herstellung von in waessrigen Loesungen bestaendigen Abkoemmlingen des2-Methyl-4-amino-naphthols-(1) | |
| DE1953338C3 (de) | Acylderivate des Antibiotikums T-2636C und Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel | |
| DE69901819T2 (de) | Neue kristallkomplexe von baccatin iii mit imidazol, 2-methylimidazol or isopropanol |